Comunicados de prensa

China Medical University Hospital Treats First Patient with Ethos™ Therapy in Taiwan, Expanding Access to Personalized Cancer Care

Varian, a Siemens Healthineers company, announced today that China Medical University Hospital in Central Taiwan treated its first patient with Ethos™ therapy, making it the first hospital in...

Icon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from Varian

Varian, a Siemens Healthineers company, announced today that cancer patients in Australia will be the first in the world to benefit from streamlined, coordinated cancer care facilitated by an...

Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)

Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its cardiac radioablation (CRA)...

News Items

Varian Installs Cyclotron at National Taiwan University Cancer Center

Installation marks milestone for first ProBeam system in Taiwan Varian announced the installation of the cyclotron for its ProBeam® proton therapy system at the National Taiwan University Cancer Center (NTUCC). The cyclotron is a core piece of…

Varian and Yonsei Cancer Center, Yonsei University Health System Sign MOU to Further Innovation to Treat Cancer Patients

Varian announced that it has entered into a three-year agreement with Yonsei Cancer Center, Yonsei University Health System to collaborate on research and development projects in the field of radiation therapy and oncology. Cancer is the leading…

Varian Partners with Sony Foundation Australia in the You Can Stay Program

Varian announced it has entered a partnership with Sony Foundation Australia to support its You Can Stay Program. The You Can Stay program provides free accommodations for cancer patients aged between 15 to 25 and their families in Australia who…

Publicaciones del blog

An Industry/Academic Partnership Yields Fruit: An Ultra-High Dose Rate Beam Monitoring Tool for FLASH Trials


Varian, in partnership with the Danish Centre for Particle Therapy (DCPT) at Aarhus University Hospital and the Cincinnati Children’s Hospital/UC Health Proton Therapy Center—two members of the FlashForward™ Consortium—has tested a specialized dose monito...

Más información

Henry Ford Cancer Institute (HFCI), Michigan: Looking Towards Adaptation During Five-Fraction SBRT


Henry Ford Allegiance (HFA) is a community-based hospital about 60 miles west of the main Henry Ford Health System campus. Its HFCI radiation oncology clinic treats approximately 450 patients a year, with more than 9,000 external beam treatments delivered...

Más información

Ethos Adaptive Radiotherapy: Redefining Cancer Treatment


The use of online adaptive radiotherapy has expanded around the world since Varian introduced Ethos™ therapy at ASTRO in 2019. Through groups such as the Adaptive Intelligence Consortium, research continues to show that adaptive treatment can enable dose ...

Más información

Image Gallery

Brachytherapy Treatment Planning Systems
Clinac® iX medical linear accelerator, rotating
Ethos™ therapy
Ethos™ therapy